Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Mendes is active.

Publication


Featured researches published by A. Mendes.


Journal of Hepatology | 2011

707 LONG-TERM DE-NOVO LAMIVUDINE + ADEFOVIR COMBINATION THERAPY IN CHRONIC HEPATITIS B IS EFFICIENT, BUT HAS NEGATIVE IMPACT ON RENAL/BONE SAFETY IN COMPARISON TO ENTECAVIR MONOTHERAPY

I. Carey; A. Mendes; Deepak Joshi; M. Bruce; S. Knighton; A. Scalori; A. Gera; S. Hughes; M. Al-Freah; Abid Suddle; Kosh Agarwal; Phillip Harrison


Journal of Hepatology | 2010

435 LOW NK CELL NUMBER, LOW HCV-SPECIFIC IL-10 PRODUCTION AND HIGH CD56BRIGHT CELL NUMBER PREDICT RESPONSE TO PEGYLATED-INTERFERON/RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C IN CHILDREN

I. Carey; A. Mendes; Dita Cebecauerová; Sanjay Bansal; Pushpa Subramaniam; S. Tizzard; Giorgina Mieli-Vergani; Diego Vergani


Journal of Hepatology | 2012

773 RS12979860 CC GENOTYPE IS ASSOCIATED WITH BASELINE HIGH NUMBERS OF CD56BRIGHT NK-CELLS, LOW NUMBERS OF CD3-CD56-CD16– CELLS, LOW IL-10 HCV-SPECIFIC PRODUCTION IN CH-C THERAPY RESPONDERS

I. Carey; M. Bruce; Deepak Joshi; A. Mendes; A. Scalori; Kosh Agarwal; Diego Vergani


Journal of Hepatology | 2011

407 EARLY ON-TREATMENT HAEMATOLOGICAL PARAMETERS AND GENOTYPE PREDICT RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY IN CHRONIC HEPATITIS C CIRRHOSIS

I. Carey; A. Mendes; Deepak Joshi; A. Gera; S. Knighton; M. Al-Freah; Abid Suddle; Kosh Agarwal


Journal of Hepatology | 2011

1145 HIGH NUMBERS OF CD56BRIGHT, CD56DIM/NKG2D+ AND LOW NUMBERS OF CD3 CD56 CD16+ NK-CELLS ARE ASSOCIATED WITH LOW HCV-SPECIFIC IL-10 PRODUCTION AND PREDICT TREATMENT-RESPONSE IN CHRONIC HEPATITIS C

I. Carey; A. Mendes; A. Scalori; Deepak Joshi; Kosh Agarwal; G. Mieli-Vergani; Diego Vergani


Hepatology | 2011

SWITCH TO OTHER NUCLEOS(T)IDE ANALOGUES THERAPY IN CHRONIC HEPATITIS B COHORT ON LONG-TERM DE-NOVO COMBINATION THERAPY WITH LAMIVUDINE PLUS ADEFOVIR: EFFICACY AND SAFETY

I. Carey; A. Mendes; Deepak Joshi; Mohammad A. Al-Freah; S Knighton; Sarah A. Hughes; M. Bruce; Astrid Scalori; Abid Suddle; Phillip Harrison; Kosh Agarwal


Journal of Hepatology | 2010

683 LOW PRE-TREATMENT NUMBERS OF CD4+/PD1+ LYMPHOCYTES AND LOW HCV-SPECIFIC IL-10 PRODUCTION DURING THERAPY WITH PEGYLATED-INTERFERON+RIBAVIRIN PREDICT RESPONSE IN CHILDREN WITH CHRONIC HEPATITIS C

I. Carey; A. Mendes; Dita Cebecauerová; Sanjay Bansal; Pushpa Subramaniam; S. Tizzard; G. Mieli-Vergani; Diego Vergani


Journal of Hepatology | 2010

434 HIGH FREQUENCY OF POLYFUNCTIONAL NATURAL KILLER CELLS WITH HIGH EXPRESSION OF NKG2D IS LINKED TO HBV-SPECIFIC T-HELPER TYPE 1 IMMUNE CONTROL

I. Carey; A. Mendes; Sanjay Bansal; Giorgina Mieli-Vergani; Diego Vergani


Hepatology | 2010

COMBINED INNATE AND ADAPTIVE IMMUNE RESPONSES ARE NEEDED TO CONTROL HBV REPLICATION IN CHILDREN WITH INFANCY-ACQUIRED INFECTION

I. Carey; Sanjay Bansal; A. Mendes; Giorgina Mieli-Vergani; Diego Vergani


Hepatology | 2009

EFFICACY AND SAFETY OF LAMIVUDINE PLUS ADEFOVIR DE NOVO COMBINATION THERAPY COMPARED TO ENTECAVIR MONOTHERAPY IN CHRONIC HEPATITIS B: A SINGLE CENTRE CLINICAL PRACTICE EXPERIENCE

I. Carey; A. Mendes; S. Hughes; Astrid Scalori; Abid Suddle; Kosh Agarwal; Phillip Harrison

Collaboration


Dive into the A. Mendes's collaboration.

Top Co-Authors

Avatar

I. Carey

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar

Kosh Agarwal

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Abid Suddle

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar

Deepak Joshi

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Bruce

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge